Invest now
Pfizer Cash Flow Annual
BSE: 500680 | NSE: PFIZER | ISIN: INE182A01018 | Sector: Major Drugs4,060.15 -36.10 (-0.88%)Updated : 11 Sep 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Issuance( Retirement)of Debt Net | -38.17 | -37.31 | -41.05 | -35.20 |
| Net Changein Cash | -392.41 | 383.07 | 75.40 | -26.16 |
| Cash Taxes Paid | -14.53 | 156.22 | 153.82 | 302.58 |
| Net Income/ Starting Line | 975.67 | 1,016.09 | 746.07 | 824.01 |
| Total Cash Dividends Paid | -751.64 | -160.25 | -183.43 | -297.21 |
| Changesin Working Capital | 54.72 | -99.43 | -399.91 | -337.07 |
| Cashfrom Operating Activities | 967.57 | 659.75 | 256.84 | 355.68 |
| Cash Interest Paid | 8.50 | 7.78 | 10.66 | 13.38 |
| Cashfrom Financing Activities | -798.31 | -205.34 | -235.14 | -345.79 |
| Depreciation/ Depletion | 57.73 | 60.79 | 62.28 | 105.51 |
| Other Investing Cash Flow Items Total | -536.44 | -43.19 | 72.63 | 28.93 |
| Capital Expenditures | -25.23 | -28.15 | -18.93 | -64.98 |
| period Type | - | - | - | - |
| Non- Cash Items | -120.55 | -317.70 | -151.60 | -236.77 |
| Financing Cash Flow Items | -8.50 | -7.78 | -10.66 | -13.38 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -561.67 | -71.34 | 53.70 | -36.05 |
*All figures in crores except per share values
Pfizer Quick Links
Pfizer Dividend Pfizer Bonus Pfizer News Pfizer AGM Pfizer Rights Pfizer Splits Pfizer Board Meetings Pfizer Key Metrics Pfizer Shareholdings Pfizer Profit Loss Pfizer Balance Sheet Pfizer Q1 Results Pfizer Q2 Results Pfizer Q3 Results Pfizer Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
272.00+6.05(2.27%)
1,260.00+20.50(1.65%)
11,053.00+157.00(1.44%)
1,196.80-29.75 (-2.43%)
185.95-2.60 (-1.38%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.